Glanbia Nutritionals is seeking to propel its growth in China via general lifestyle nutrition, in addition to its sports nutrition stronghold, with a key focus on creating new concepts in tandem with its customers.
Read about Blackmores' strategy overhaul in the wake of weak Q3 results, Bod Australia's continuing CBD innovations, Sirio Pharma's global R&D plans, and probiotics news from BLIS Technologies and Indian start-up MO's Superfoods.
Tmall reveals China's top seven F&B trends, a Singapore-based sports nutrition retailer tells us about its plans to shake up the industry, and we bring you the latest on our upcoming Healthy Ageing APAC Summit and NutraIngredients-Asia Awards.
Read about who won big at Natural Health Products New Zealand industry awards, China's crackdown on health foods and probiotics regulations, and the latest research and innovations in the Oceanic region.
Read about latest the regulatory developments in China, Blackmores' acerbic response to the MBA's "attack" on complementary medicine, and the mystery of India's missing fortified flour in our regulatory review.
Indena is striving for APAC growth with market entry in Japan and China, and launching a more bioavailable formulation of coenzyme Q10 (CoQ10), which the firm believes has potential for success in sports nutrition and beyond.
The recent slew of crackdowns, regulatory reviews and stricter rules for China's health food and supplement industry are 'growing pains' the industry must overcome, as regulators double down on efforts to promote safety and collect taxes.